223 results on '"Zenke Y"'
Search Results
2. 059 Possible involvement of innate immune cells expressing the macrophage galactose-type C-type lectin in inflammatory skin diseases
3. 46P Multi-center, phase II study of docetaxel (DTX) plus ramucirumab (RAM) following platinum-based chemotherapy plus ICIs in patients with NSCLC: SCORPION study
4. P1.12A.02 Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with NSCLC Harboring EGFR Exon 19 Insertions: A Report from the LC-SCRUM-Asia.
5. MA17.04 Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC.
6. 1015P Phase III study of ramucirumab plus docetaxel versus atezolizumab for PD-L1 negative or weakly positive advanced non-small cell lung cancer after disease progression on platinum-based therapy: WJOG10317L study (EMERALD)
7. EP08.02-113 Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
8. 997P Phase I study of brigatinib plus panitumumab in patients with advanced EGFR-mutated non-small cell lung cancer resistant to osimertinib (BEBOP): Early termination due to severe early onset pneumonitis by brigatinib
9. MA13.07 TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC
10. LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial
11. P47.14 Study Design of SCORPION: Multi-Center, Phase II Study Following Platinum-Based Chemotherapy Plus ICIs in Patients with NSCLC
12. 1276P Genomic screening by multi-gene assay for perioperative targeted therapy in patients with early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD
13. 1282P Concordance of PD-L1 expression between biopsy and matched surgical specimen in early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD
14. 236TiP Large-scale prospective observational study to develop a liquid-based detection system of minimal residual disease (MRD): LC-SCRUM-MRD
15. 1356P 10-year survivors treated with tyrosine kinase inhibitor for advanced non-small cell lung cancer
16. Shorter unipedal standing time and lower bone mineral density in women with distal radius fractures
17. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332
18. P02.03 Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.
19. P89.06 Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer
20. Long-term outcomes after the intra-articular distal radius fractures with volar locking plate
21. Long-term Outcomes of Surgically Treated Metacarpal Fractures Using Bioabsorbable Plates
22. 099 Competition for active TGFβ eliminates bystander CD8+ TRM from the epidermal niche
23. The effect of an associated ulnar styloid fracture on the outcome after fixation of a fracture of the distal radius
24. Initial results of lung cancer genomic screening project for individualized medicine in Asia: LC-SCRUM-Asia
25. Histological type analysis of 10-year follow-up of WJTOG0105: A phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer
26. MA13.07 Phase I/II Study of Carboplatin Plus Weekly Nab-Paclitaxel in Aged ≥75 Patients with Squamous-Cell Lung Cancer: TORG1322
27. P1.18-04 Neoadjuvant Ceritinib for Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: SAKULA Trial
28. Clinical utility of precision immunoprofiling and monitoring of the tumour microenvironment using flow cytometry and CyTOF in patients with advanced NSCLC treated with atezolizumab: Results from a phase II study for biomarker analysis (EPOC1702)
29. OA01.05 Cryobiopsy Compared with Forceps Biopsy in Pathological Diagnosis and Biomarker Research in Lung Cancer: A Prospective, Single-Arm Study
30. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer: 10-year follow-up of West Japan thoracic oncology group WJTOG0105
31. P2.04-72 Clinical Feature and Management of Acquired Resistance to PD-1 Inhibitor in Advanced NSCLC
32. 043 Keratinocyte-mediated activation of TGFβ maintains skin-recirculating memory CD8+ T cells
33. Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
34. 982 Keratinocytes derived TGFβ is not required for immune homeostasis in mouse skin
35. 519P - Initial results of lung cancer genomic screening project for individualized medicine in Asia: LC-SCRUM-Asia
36. 468P - Histological type analysis of 10-year follow-up of WJTOG0105: A phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer
37. 1458PD - Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer: 10-year follow-up of West Japan thoracic oncology group WJTOG0105
38. 1242P - Clinical utility of precision immunoprofiling and monitoring of the tumour microenvironment using flow cytometry and CyTOF in patients with advanced NSCLC treated with atezolizumab: Results from a phase II study for biomarker analysis (EPOC1702)
39. Correlation Between Grip Strength and Forearm Bone Mineral Density in Women Over 60 Years of Age
40. 1467P - Efficacy and safety of nivolumab for cytotoxic chemotherapy unfit patients with advanced non-small cell lung cancer: A phase II study
41. 3034 Mutational profile of targetable oncogenes in younger adult patients with lung adenocarcinoma
42. Ulnar styloid process nonunion and outcome in patients with a distal radius fracture: A meta-analysis of comparative clinical trials
43. A Nationwide Genomic Screening System in Japan for the Development of Molecular Targeted Therapies Against Non-Small Cell Lung Cancers with Rare Driver Mutations
44. Tolerability of Standard Dose of Platinum-Based Chemotherapy in Fit Elderly Patients with Non-Small Cell Lung Cancer
45. Shorter unipedal standing time and lower bone mineral density in women with distal radius fractures
46. 1307P - A Nationwide Genomic Screening System in Japan for the Development of Molecular Targeted Therapies Against Non-Small Cell Lung Cancers with Rare Driver Mutations
47. A case of vancomycin-associated linear Ig A bullous dermatosis and Ig A antibodies to the α3 subunit of laminin-332.
48. Mechanical comparison of novel bioabsorbable plates with titanium plates and small-series clinical comparisons for metacarpal fractures.
49. Clinical results of volar locking plate for distal radius fractures: conventional versus minimally invasive plate osteosynthesis.
50. Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.